Genedx Holdings (WGS) | Stock Overview & Key Data
Genedx Holdings Performance Comparison
Stock Range
Today's Range
Low: $121.00
High: $127.36
on August 15, 2025
52 Week Range
Low: $28.86
High: $127.36
on September 5, 2024
on August 15, 2025
All-Time High: $417.42 on August 9, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$3.5B
EPS
0.08
P/E Ratio (TTM)
1,507.81
Forward P/E
246.17
P/B Ratio
12.50
PEG Ratio
-11.21
Div. Yield
N/A
ROE
0.60%
Beta
2.081
Debt to Equity
41.27
Financial Highlights
Profitability
Gross Margin
69.04%
Operating Margin
8.73%
Profit Margin
0.39%
Returns and Earnings
Return on Assets (TTM)
1.05%
Return on Equity (TTM)
0.60%
EBITDA
$12.1M
Net Income (TTM)
$1.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$12.93
Quarterly Revenue Growth (YoY)
45.60%
Quarterly Earnings Growth (YoY)
45.63%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Genedx Holdings WGS | 3.47B Mid-cap | 20.19% | 54.68% | 98.65% | 12.06% | 58.68% | 265.52% | 221.77% | 1,189.39% |
| Thermo Fisher TMO | 182.59B Large-cap | 6.14% | 16.99% | 20.76% | -6.52% | -6.42% | -19.04% | -16.91% | 14.10% |
| Danaher DHR | 151.04B Large-cap | 5.17% | 9.37% | 10.46% | 3.13% | -8.22% | -21.68% | -18.64% | 14.50% |
| Exact Sciences EXAS | 8.63B Mid-cap | 11.25% | -13.95% | -18.82% | -8.12% | -19.90% | -22.38% | 23.81% | -43.12% |
| Charles River CRL | 7.71B Mid-cap | 5.34% | 1.46% | 12.81% | 1.48% | -14.21% | -22.39% | -27.99% | -27.59% |
| Guardant Health GH | 7.34B Mid-cap | 8.57% | 22.44% | 45.53% | 21.98% | 85.33% | 110.66% | 23.28% | -37.01% |
Ownership & Short Interest
Insider Ownership
12.46%
Institutional Ownership
108.46%
Shares Short
4M
Short Ratio
3.87
Short % of Shares Outstanding
25.40%
Average 10-Day Volume
695K
Average 90-Day Volume
866K
Genedx Holdings Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Genedx Holdings would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is WGS's 52-week high and low?
- In the last 52 weeks, Genedx Holdings reached a high of $127.36 (on August 15, 2025) and a low of $28.86 (on September 5, 2024).
- What is the market cap and P/E ratio for WGS?
- Curious about Genedx Holdings's size and valuation? Its market capitalization stands at 3.47B. When it comes to valuation, the P/E ratio (trailing twelve months) is 1,507.81, and the forward P/E (looking ahead) is 246.17.
- Does WGS pay dividends? If so, what's the yield?
- As for dividends, Genedx Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Genedx Holdings's main competitors or similar companies to consider before investing?
When looking at Genedx Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO182.59B Healthcare Diagnostics & Research -19.04% -16.91% Danaher
DHR151.04B Healthcare Diagnostics & Research -21.68% -18.64% Exact Sciences
EXAS8.63B Healthcare Diagnostics & Research -22.38% 23.81% Charles River
CRL7.71B Healthcare Diagnostics & Research -22.39% -27.99% Guardant Health
GH7.34B Healthcare Diagnostics & Research 110.66% 23.28% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Genedx Holdings Corp? (e.g., ROE, Debt/Equity)
- To get a sense of Genedx Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.60%, the Debt to Equity ratio from the most recent quarter is 41.27, and its Gross Profit Margin stands at 69.04%.
- What is the recent revenue and earnings growth for WGS?
- Looking at Genedx Holdings's growth, its revenue over the trailing twelve months (TTM) was $362M. Compared to the same quarter last year (YoY), quarterly revenue grew by 45.60%, and quarterly earnings saw a YoY growth of 45.63%.
- How much of WGS stock is held by insiders and institutions?
- Wondering who owns Genedx Holdings stock? Company insiders (like executives and directors) hold about 12.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 108.46%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.